BridgeBio Pharma, Inc. Common Stock (BBIO) Stock Price, Quote & AI Analysis
Live BBIO stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for BridgeBio Pharma, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for BridgeBio Pharma, Inc. Common Stock (BBIO), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
BridgeBio Pharma, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
BridgeBio Pharma, Inc. Common Stock Overview
Company information
Company Overview
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
BridgeBio Pharma, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...